Loading clinical trials...
Loading clinical trials...
This is a safety study of tandutinib in combination with temozolomide and bevacizumab after people have received radiation therapy and temozolomide treatment. This study will determine the maximum saf...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Millennium Pharmaceuticals, Inc.
NCT05303467 · Glioblastoma Multiforme, Recurrent Glioblastoma
NCT07464925 · Glioblastoma Multiforme of Brain, Glioma, and more
NCT05954858 · Glioma, Malignant, Glioblastoma, and more
NCT01269853 · Glioblastoma Multiforme, Anaplastic Astrocytoma
NCT05271240 · Glioblastoma, Glioblastoma Multiforme, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions